UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
January 28, 2003
------------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------------- ----------- --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
-------------------------------------------------------
(Address of principal executive offices)
336-229-1127
------------
(Registrant's telephone number, including area code)
ITEM 9. Regulation FD Disclosure.
Laboratory Corporation of America -Registered Trademark-
Holdings (LabCorp -Registered Trademark-)(NYSE:LH) announced
that Thomas P. Mac Mahon, chairman and chief executive officer,
is scheduled to speak at the US Bancorp Piper Jaffray Health Care
Conference in New York on January 29, 2003 at 4:00 p.m. Eastern
Time. At the conference, the Company will reiterate its guidance
for 2002 and 2003, as filed in an 8K on October 30, 2002, A live
audio Webcast of the presentation will be available via the company
Web site at www.labcorp.com. A replay of the audio Webcast will begin
shortly following the actual presentation and will be available through
February 14, 2003.
The Company also announced that its results for the fourth quarter and
full year 2002 are scheduled to be released after markets close on
February 18, 2003. A live broadcast of LabCorp's quarterly conference
call on February 19, 2003 will be available online at www.labcorp.com or
at www.streetevents.com beginning at 9:00 a.m. Eastern Time, with an online
rebroadcast continuing through March 19, 2003. The live call at 9:00 a.m.
will also be available in a listen-only mode by dialing 212-896-6113. A
telephone replay of the call will be available through February 26, 2003
and can be heard by dialing 800-633-8284 (402-977-9140 for international
callers). The access code for the replay is 211-16-073.
Each of the above forward-looking statements is subject to
change based on various important factors, including without
limitation, competitive actions in the marketplace and
adverse actions of governmental and other third-party
payors. Actual results could differ materially from those
suggested by these forward-looking statements. Further
information on potential factors that could affect LabCorp's
financial results is included in the Company's Form 10-K
for the year ended December 31, 2001 and subsequent SEC filings,
and will be available in the Company's 10-K for the year ended
December 31,2002, when filed.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
----------------------------------
Bradford T. Smith
Executive Vice President
and Secretary
Date: January 28, 2003